Clinical Trials Browser

Phase 2 × Endometrial Neoplasms × Gene Expression Profiling × Clear all

NCT00770185 2023-08-04

Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer

Phase 2 Completed

Endometrial Neoplasms